We’re  raising a glass to the companies in the Park that achieved high-tech and entrepreneurial advances over the past year! Celebrate along with the community at the Toast the Town Holiday Party on Dec. 17 hosted by the UVA Licensing & Ventures Group, Charlottesville Business Innovation Council, and Virginia Bio, and follow-along on twitter with #cvilletechtoast.

ContraVac, Inc.

• Target stores accepted SpermCheck Fertility for US national distribution. Previous US national distribution included Walgreens, CVS and Rite Aid.
• A second product was added to the product line: FertileCheck Fertility Gel, a transparent gel which mimics women natural fertility fluids to create a sperm-friendly environment for improved fertilization conditions.

Klockner Pentaplast

• Opened new, state-of-the-art kp i.center at the UVA Research Park –  home to the newly expanded BlisterPro® XCEL.

Neoantigenics

• Closed on a $3.0 million Series A Preferred Stock Offering.
• Developed several monoclonal antibodies targeting their tumor specific protein SAS1B. In vitro testing of these monoclonal antibodies conjugated with a cancer drug payload  has shown very strong activity for tumor cell killing. This type of therapeutic is known as an antibody-drug-conjugate or ADC. These ADC’s will now be advanced to in vivo testing in mice.

UVa Center for Applied Biomechanics

• The National Highway Traffic Safety Administration (NHTSA) recently announced a major change in the New Car Assessment Program (NCAP) star rating system which is in great part due to the off-set/oblique crash testing accomplished by CAB for NHTSA.
• Dr. Matthew Panzer and his computational team at CAB are leading the development of a state-of-the-art digital model of a small female vehicle occupant for use in computer-simulated vehicle crashes. The development of this tool will allow automotive manufacturers the ability to improve safety equipment and injury countermeasures for some of our society’s most vulnerable occupants.

#cvilletechtoast Tweets